XML 47 R21.htm IDEA: XBRL DOCUMENT v3.2.0.727
STOCKHOLDERS' EQUITY (Tables)
6 Months Ended
Jun. 30, 2015
Stockholders' Equity Note [Abstract]  
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]
The following table summarizes stock option activity for the three months ended June 30, 2015:
 
 
 
Number
of shares
 
Weighted-
average
exercise price
 
Weighted-
average
Contractual Term
 
Aggregate
Intrinsic Value
 
 
 
 
 
 
 
 
 
(in years)
 
 
 
 
Outstanding at December 31, 2014
 
 
194
 
$
971.70
 
 
3.50
 
$
 
Granted
 
 
 
 
 
 
 
 
 
 
 
Exercised
 
 
 
 
 
 
 
 
 
 
 
Forfeited
 
 
 
 
 
 
 
 
 
 
 
Expired
 
 
(42)
 
 
2,811.53
 
 
 
 
 
 
 
Outstanding at June 30, 2015
 
 
152
 
$
463.32
 
 
3.97
 
$
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Exercisable at June 30, 2015
 
 
152
 
$
463.32
 
 
3.97
 
$
 
Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]
The following table summarizes restricted share activity for the six months ended June 30, 2015:
 
 
 
Number of Shares
 
Weighted Average
Grant Date
Fair Value
 
Outstanding at December 31, 2014
 
 
6,400,001
 
$
5.86
 
Granted
 
 
471,592
 
 
16.03
 
Vested
 
 
(813,997)
 
 
4.99
 
Forfeited
 
 
(1,166)
 
 
10.53
 
Outstanding at June 30, 2015
 
 
6,056,430
 
$
6.77
 
Schedule Of Warrants Activity [Table Text Block]
The following table summarizes warrant activity for the six months ended June 30, 2015:
 
 
 
Warrants
 
Weighted-
average
exercise price
 
Aggregate
Intrinsic Value
 
Outstanding at December 31, 2014
 
 
4,148,228
 
$
0.94
 
$
61,792,184
 
Issued
 
 
 
 
 
 
 
 
Exercised
 
 
(2,918,115)
 
 
0.34
 
 
 
 
Expired
 
 
(11,364)
 
 
2.25
 
 
 
 
Outstanding at June 30, 2015
 
 
1,218,749
 
$
2.37
 
$
17,327,944
 
Schedule Of Share Based Compensation Expense [Table Text Block]
The following table summarizes stock-based compensation expense information about stock options and restricted stock for the three and six months ended June 30, 2015:
 
 
 
Three months ended
June 30, 2015
 
Six months ended
June 30, 2015
 
Stock-based compensation expense associated with restricted stock
 
$
6,242,986
 
$
11,600,014
 
Stock-based compensation expense associated with option grants
 
 
 
 
 
 
 
$
6,242,986
 
$
11,600,014